Integral Health Asset Management, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001773206

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q3 2026 · 94 positions · Total reported value $1.54B · Top-10 concentration 41.9% · Updated 2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

Turnover: 75.2% · 35 new · 28 cut · 31 exited

Active Share (vs S&P 500): 97.5% · vs QQQ: 98.1% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -11.2% · vs SPY -13.3% · Prev Value $2.22B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -0.3% · vs SPY -2.5% · Latest Value $1.54B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Integral Health Asset Management, LLC disclosed 94 equity positions with a combined reported value of $1.54B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 41.9% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were RVMD ($130.34M), INSM ($128.98M), CYTK ($72.50M). By sector, the heaviest allocations are Health Care 96.1%, Industrials 1.7%. Versus the prior quarter, allocation shifted toward Health Care (+3.1pp), Industrials (+0.7pp) and away from Consumer Staples (-3.7pp).

Versus the prior quarter, Integral Health Asset Management, LLC opened 35 new positions, trimmed 28 and fully exited 31, a turnover rate of 75.2% of positions. The portfolio's overlap with the prior quarter was 47% of names.

The largest new positions opened in Q3 2026 were AMGN ($31.61M), INCY ($19.42M), ONC ($18.30M).

Of the 31 positions fully exited versus the prior quarter, the largest were ALHC ($47.62M), ABT ($36.30M), UNH ($35.33M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • AMGN AMGEN INC · $31.61M
  • INCY INCYTE CORP · $19.42M
  • ONC BEONE MEDICINES LTD · $18.30M
  • BDX BECTON DICKINSON & CO · $17.90M
  • EHC ENCOMPASS HEALTH CORP · $14.58M
  • BMY BRISTOL-MYERS SQUIBB CO · $12.48M
  • TEVA TEVA PHARMACEUTICAL INDS LTD · $11.88M
  • SRZN SURROZEN INC · $10.46M

Fully Exited (vs previous quarter)

  • ALHC ALIGNMENT HEALTHCARE INC · prev qtr: $47.62M
  • ABT ABBOTT LABORATORIES · prev qtr: $36.30M
  • UNH UNITEDHEALTH GROUP INC · prev qtr: $35.33M
  • LNTH LANTHEUS HLDGS INC · prev qtr: $21.08M
  • ELV ELEVANCE HEALTH INC FORMERLY · prev qtr: $19.34M
  • LLY ELI LILLY & CO · prev qtr: $17.99M
  • ARWR ARROWHEAD PHARMACEUTICALS IN · prev qtr: $16.30M
  • NVST ENVISTA HOLDINGS CORPORATION · prev qtr: $15.81M

Insider Transactions (Form 4)

Latest Integral Health Asset Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Integral Health Asset Management, LLC, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 90 positions worth $2.22B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-119048 (status: Approved), registered 2020-07-14
  • Regulatory AUM (Form ADV): $1.87B as of 2026-03-26
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds
  • Website: integralhlth.com

Portfolio Structure

  • 90 positions · $2.22B reported value (Q2 2026)
  • Top 10 holdings = 41.0% of reported value
  • Largest position: INSM (INSMED INC) at 7.7%
  • Average position size: $24.69M

Sector Tilt

  • Health Care 92.9%
  • Consumer Staples 5.1%
  • Industrials 1.1%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 28 new, 25 added, 22 reduced, 24 exited
  • 15 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: The fund is actively increasing exposure to high-growth biotech/healthcare names (RVMD, SRRK, CNC) and large-cap healthcare (MRK, AMGN), while reducing positions in smaller/mid-cap biotechs (AXSM, VERA, LFST), suggesting a tactical tilt toward larger, more established players with potential upside. 2. Key moves: - Added: RVMD (shares +233.3%), MRK (+28.6%), SRRK (+67.3%), CNC (+150.0%). - Reduced: AXSM (-16.7%), VERA (-14.3%), LFST (-13.3%). - New: AMGN (initial position). - Held: INSM, CYTK. 3. Portfolio structure: Active, concentrated (94 positions), heavily biased toward Health Care (100% of top 10). Moderate risk appetite—mix of high-growth biotech (RVMD, SRRK) and stable large-caps (MRK, AMGN). 4. Per-holding one-liner: - RVMD: Biotech developing cancer therapies (unverified). - INSM: Biotech focused on rare diseases (unverified). - CYTK: Biotech targeting muscular/heart diseases (unverified). - MRK: Large-cap pharmaceutical (Merck). - SRRK: Biotech developing muscle-targeted therapies (unverified). - CNC: Managed healthcare provider (Centene). - AXSM: Biotech pain therapeutics (unverified). - VERA: Biotech kidney/immunology drugs (unverified). - AMGN: Large-cap biotech (Amgen). - LFST: Mental healthcare provider (Lifestance). 5. Style summary: The fund tactically shifted toward larger, more established healthcare names while selectively boosting high-growth biotech positions, reducing exposure to smaller/mid-cap biotechs.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 04:31

Sector Allocation

Health Care 96.1%
Other 0.8%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 1.00M $130.34M 8.45%
8.45%
Add
2 1.60M $128.98M 8.36%
8.36%
Hold
3 1.60M $72.50M 4.70%
4.70%
Hold
4 450.00K $65.39M 4.24%
4.24%
Add
5 1.25M $60.64M 3.93%
3.93%
Add
6 750.00K $46.59M 3.02%
3.02%
Add
7 250.00K $46.10M 2.99%
2.99%
Reduce
8 1.50M $32.29M 2.09%
2.09%
Reduce
9 75.00K $31.61M 2.05%
2.05%
New
10 2.60M $31.28M 2.03%
2.03%
Reduce
11 40.00K $30.33M 1.97%
1.97%
Hold
12 90.00K $23.00M 1.49%
1.49%
Reduce
13 100.00K $22.59M 1.46%
1.46%
Hold
14 1.00M $22.45M 1.46%
1.46%
Hold
15 100.00K $22.25M 1.44%
1.44%
Reduce
16 500.00K $21.42M 1.39%
1.39%
Reduce
17 150.00K $21.28M 1.38%
1.38%
Hold
18 40.00K $20.91M 1.35%
1.35%
Hold
19 1.70M $20.20M 1.31%
1.31%
Reduce
20 300.00K $19.74M 1.28%
1.28%
Add
21 160.00K $19.42M 1.26%
1.26%
New
22 500.00K $19.03M 1.23%
1.23%
Reduce
23 325.00K $18.44M 1.20%
1.20%
Reduce
24 50.00K $18.30M 1.19%
1.19%
New
25 2.00M $18.29M 1.19%
1.19%
Hold
26 470.00K $18.04M 1.17%
1.17%
Add
27 100.00K $17.90M 1.16%
1.16%
New
28 400.00K $17.46M 1.13%
1.13%
Reduce
29 200.00K $17.26M 1.12%
1.12%
Reduce
30 1.13M $16.57M 1.07%
1.07%
Add
31 375.00K $15.20M 0.98%
0.98%
Add
32 175.00K $15.10M 0.98%
0.98%
Reduce
33 90.00K $14.78M 0.96%
0.96%
Reduce
34 120.00K $14.58M 0.94%
0.94%
New
35 100.00K $14.26M 0.92%
0.92%
Reduce
36 1.30M $14.00M 0.91%
0.91%
Add
37 55.00K $12.82M 0.83%
0.83%
Reduce
38 500.00K $12.77M 0.83%
0.83%
Hold
39 25.00K $12.60M 0.82%
0.82%
Hold
40 200.00K $12.48M 0.81%
0.81%
New
41 300.00K $12.18M 0.79%
0.79%
Reduce
42 500.00K $12.08M 0.78%
0.78%
Reduce
43 250.00K $11.90M 0.77%
0.77%
Reduce
44 300.00K $11.88M 0.77%
0.77%
New
45 200.00K $11.78M 0.76%
0.76%
Reduce
46 40.00K $11.65M 0.76%
0.76%
Hold
47 150.00K $11.47M 0.74%
0.74%
Reduce
48 25.00K $10.98M 0.71%
0.71%
Reduce
49 325.00K $10.46M 0.68%
0.68%
New
50 150.00K $10.40M 0.67%
0.67%
Add

FAQ

What did Integral Health Asset Management, LLC buy in 2026-Q3?

In its 2026-Q3 13F filing, Integral Health Asset Management, LLC reported 94 equity positions worth $1.54B in aggregate; its largest disclosed positions were RVMD ($130.34M), INSM ($128.98M), CYTK ($72.50M).

How large is Integral Health Asset Management, LLC's portfolio?

Integral Health Asset Management, LLC reported $1.54B of long equity holdings across 94 positions as of 2026-Q3. Top-10 holdings account for 41.9% of reported value.

What is Integral Health Asset Management, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/integral-health-asset-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →